Generics Global Industry Guide 2017-2021

Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the global generics market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

Key Highlights

– For the purposes of this profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.

The market value is evaluated at ex-factory prices.

Market volume is quantified here as the percentage of the total ethical pharmaceutical market volume in a country or region which is accounted for by generic drugs. It is therefore a generics penetration rate measure, not an absolute measure of market volume.

Regional volumes are calculated as weighted averages of countries which make up the region in question where volume data exists.

Please note that any volumes of "1" (one) or 100% are due to rounding as MarketLine does not believe that generics will ever fully represent 100% of the medicinal market in any country or region.

All currency conversions were calculated at constant average annual 2016 exchange rates.

– The global generics market had total revenues of $311.1bn in 2016, representing a compound annual growth rate (CAGR) of 9.5% between 2012 and 2016.

– Market consumption volume increased with a CAGR of 2.2% between 2012 and 2016, to reach a total of 82.1% of total pharma volume in 2016.

– Strong growth will continue in the emerging markets but worldwide there will be a deceleration.

Scope

– Save time carrying out entry-level research by identifying the size, growth, and leading players in the global generics market

– Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global generics market

– Leading company profiles reveal details of key generics market players’ global operations and financial performance

– Add weight to presentations and pitches by understanding the future growth prospects of the global generics market with five year forecasts by both value and volume

Reasons to buy

- What was the size of the global generics market by value in 2016?

- What will be the size of the global generics market in 2021?

- What factors are affecting the strength of competition in the global generics market?

- How has the market performed over the last five years?

- How large is the global generics market in relation to its regional counterparts?

Table of Contents

Table of Contents

EXECUTIVE SUMMARY 2

Market value 2

Market value forecast 2

Market volume 2

Market volume forecast 2

Geography segmentation 2

Introduction 19

What is this report about? 19

Who is the target reader? 19

How to use this report 19

Definitions 19

Global Generics 20

Market Overview 20

Market Data 21

Market Segmentation 23

Market outlook 24

Five forces analysis 26

Generics in Asia-Pacific 32

Market Overview 32

Market Data 33

Market Segmentation 35

Market outlook 36

Five forces analysis 38

Generics in Europe 44

Market Overview 44

Market Data 45

Market Segmentation 47

Market outlook 48

Five forces analysis 50

Generics in France 56

Market Overview 56

Market Data 57

Market Segmentation 59

Market outlook 60

Five forces analysis 62

Macroeconomic indicators 68

Generics in Germany 70

Market Overview 70

Market Data 71

Market Segmentation 73

Market outlook 74

Five forces analysis 76

Macroeconomic indicators 82

Generics in Italy 84

Market Overview 84

Market Data 85

Market Segmentation 87

Market outlook 88

Five forces analysis 90

Macroeconomic indicators 96

Generics in Japan 98

Market Overview 98

Market Data 99

Market Segmentation 101

Market outlook 102

Five forces analysis 104

Macroeconomic indicators 110

Generics in Australia 112

Market Overview 112

Market Data 113

Market Segmentation 115

Market outlook 116

Five forces analysis 118

Macroeconomic indicators 124

Generics in Canada 126

Market Overview 126

Market Data 127

Market Segmentation 129

Market outlook 130

Five forces analysis 132

Macroeconomic indicators 138

Generics in China 140

Market Overview 140

Market Data 141

Market Segmentation 143

Market outlook 144

Five forces analysis 146

Macroeconomic indicators 153

Generics in The Netherlands 155

Market Overview 155

Market Data 156

Market Segmentation 158

Market outlook 159

Five forces analysis 161

Macroeconomic indicators 167

Generics in Spain 169

Market Overview 169

Market Data 170

Market Segmentation 172

Market outlook 173

Five forces analysis 175

Macroeconomic indicators 181

Generics in The United Kingdom 183

Market Overview 183

Market Data 184

Market Segmentation 186

Market outlook 187

Five forces analysis 189

Macroeconomic indicators 195

Generics in The United States 197

Market Overview 197

Market Data 198

Market Segmentation 200

Market outlook 201

Five forces analysis 203

Macroeconomic indicators 209

Company Profiles 211

Leading Companies 211

Appendix 245

Methodology 245

About MarketLine 246

List of Tables

List of Tables

Table 1: Global generics market value: $ billion, 2012-16

Table 2: Global generics market volume: % of total pharma volume, 2012-16

Table 3: Global generics market geography segmentation: $ billion, 2016

Table 4: Global generics market value forecast: $ billion, 2016-21

Table 5: Global generics market volume forecast: % of total pharma volume, 2016-21

Table 6: Asia-Pacific generics market value: $ billion, 2012-16

Table 7: Asia-Pacific generics market volume: % of total pharma volume, 2012-16

Table 8: Asia-Pacific generics market geography segmentation: $ billion, 2016

Table 9: Asia-Pacific generics market value forecast: $ billion, 2016-21

Table 10: Asia-Pacific generics market volume forecast: % of total pharma volume, 2016-21

Table 11: Europe generics market value: $ billion, 2012-16

Table 12: Europe generics market volume: % of total pharma volume, 2012-16

Table 13: Europe generics market geography segmentation: $ billion, 2016

Table 14: Europe generics market value forecast: $ billion, 2016-21

Table 15: Europe generics market volume forecast: % of total pharma volume, 2016-21

Table 16: France generics market value: $ million, 2012-16

Table 17: France generics market volume: % of total pharma volume, 2012-16

Table 18: France generics market geography segmentation: $ million, 2016

Table 19: France generics market value forecast: $ million, 2016-21

Table 20: France generics market volume forecast: % of total pharma volume, 2016-21

Table 21: France size of population (million), 2012-16

Table 22: France gdp (constant 2005 prices, $ billion), 2012-16

Table 23: France gdp (current prices, $ billion), 2012-16

Table 24: France inflation, 2012-16

Table 25: France consumer price index (absolute), 2012-16

Table 26: France exchange rate, 2012-16

Table 27: Germany generics market value: $ million, 2012-16

Table 28: Germany generics market volume: % of total pharma volume, 2012-16

Table 29: Germany generics market geography segmentation: $ million, 2016

Table 30: Germany generics market value forecast: $ million, 2016-21

Table 31: Germany generics market volume forecast: % of total pharma volume, 2016-21

Table 32: Germany size of population (million), 2012-16

Table 33: Germany gdp (constant 2005 prices, $ billion), 2012-16

Table 34: Germany gdp (current prices, $ billion), 2012-16

Table 35: Germany inflation, 2012-16

Table 36: Germany consumer price index (absolute), 2012-16

Table 37: Germany exchange rate, 2012-16

Table 38: Italy generics market value: $ million, 2012-16

Table 39: Italy generics market volume: % of total pharma volume, 2012-16

Table 40: Italy generics market geography segmentation: $ million, 2016

Table 41: Italy generics market value forecast: $ million, 2016-21

Table 42: Italy generics market volume forecast: % of total pharma volume, 2016-21

Table 43: Italy size of population (million), 2012-16

Table 44: Italy gdp (constant 2005 prices, $ billion), 2012-16

Table 45: Italy gdp (current prices, $ billion), 2012-16

Table 46: Italy inflation, 2012-16

Table 47: Italy consumer price index (absolute), 2012-16

Table 48: Italy exchange rate, 2012-16

Table 49: Japan generics market value: $ billion, 2012-16

Table 50: Japan generics market volume: % of total pharma volume, 2012-16

Table 51: Japan generics market geography segmentation: $ billion, 2016

Table 52: Japan generics market value forecast: $ billion, 2016-21

Table 53: Japan generics market volume forecast: % of total pharma volume, 2016-21

Table 54: Japan size of population (million), 2012-16

Table 55: Japan gdp (constant 2005 prices, $ billion), 2012-16

Table 56: Japan gdp (current prices, $ billion), 2012-16

Table 57: Japan inflation, 2012-16

Table 58: Japan consumer price index (absolute), 2012-16

Table 59: Japan exchange rate, 2012-16

Table 60: Australia generics market value: $ million, 2012-16

Table 61: Australia generics market volume: % of total pharma volume, 2012-16

Table 62: Australia generics market geography segmentation: $ million, 2016

Table 63: Australia generics market value forecast: $ million, 2016-21

Table 64: Australia generics market volume forecast: % of total pharma volume, 2016-21

Table 65: Australia size of population (million), 2012-16

Table 66: Australia gdp (constant 2005 prices, $ billion), 2012-16

Table 67: Australia gdp (current prices, $ billion), 2012-16

Table 68: Australia inflation, 2012-16

Table 69: Australia consumer price index (absolute), 2012-16

Table 70: Australia exchange rate, 2012-16

Table 71: Canada generics market value: $ million, 2012-16

Table 72: Canada generics market volume: % of total pharma volume, 2012-16

Table 73: Canada generics market geography segmentation: $ million, 2016

Table 74: Canada generics market value forecast: $ million, 2016-21

Table 75: Canada generics market volume forecast: % of total pharma volume, 2016-21

List of Figures

List of Figures

Figure 1: Global generics market value: $ billion, 2012-16

Figure 2: Global generics market volume: % of total pharma volume, 2012-16

Figure 3: Global generics market geography segmentation: % share, by value, 2016

Figure 4: Global generics market value forecast: $ billion, 2016-21

Figure 5: Global generics market volume forecast: % of total pharma volume, 2016-21

Figure 6: Forces driving competition in the global generics market, 2016

Figure 7: Drivers of buyer power in the global generics market, 2016

Figure 8: Drivers of supplier power in the global generics market, 2016

Figure 9: Factors influencing the likelihood of new entrants in the global generics market, 2016

Figure 10: Factors influencing the threat of substitutes in the global generics market, 2016

Figure 11: Drivers of degree of rivalry in the global generics market, 2016

Figure 12: Asia-Pacific generics market value: $ billion, 2012-16

Figure 13: Asia-Pacific generics market volume: % of total pharma volume, 2012-16

Figure 14: Asia-Pacific generics market geography segmentation: % share, by value, 2016

Figure 15: Asia-Pacific generics market value forecast: $ billion, 2016-21

Figure 16: Asia-Pacific generics market volume forecast: % of total pharma volume, 2016-21

Figure 17: Forces driving competition in the generics market in Asia-Pacific, 2016

Figure 18: Drivers of buyer power in the generics market in Asia-Pacific, 2016

Figure 19: Drivers of supplier power in the generics market in Asia-Pacific, 2016

Figure 20: Factors influencing the likelihood of new entrants in the generics market in Asia-Pacific, 2016

Figure 21: Factors influencing the threat of substitutes in the generics market in Asia-Pacific, 2016

Figure 22: Drivers of degree of rivalry in the generics market in Asia-Pacific, 2016

Figure 23: Europe generics market value: $ billion, 2012-16

Figure 24: Europe generics market volume: % of total pharma volume, 2012-16

Figure 25: Europe generics market geography segmentation: % share, by value, 2016

Figure 26: Europe generics market value forecast: $ billion, 2016-21

Figure 27: Europe generics market volume forecast: % of total pharma volume, 2016-21

Figure 28: Forces driving competition in the generics market in Europe, 2016

Figure 29: Drivers of buyer power in the generics market in Europe, 2016

Figure 30: Drivers of supplier power in the generics market in Europe, 2016

Figure 31: Factors influencing the likelihood of new entrants in the generics market in Europe, 2016

Figure 32: Factors influencing the threat of substitutes in the generics market in Europe, 2016

Figure 33: Drivers of degree of rivalry in the generics market in Europe, 2016

Figure 34: France generics market value: $ million, 2012-16

Figure 35: France generics market volume: % of total pharma volume, 2012-16

Figure 36: France generics market geography segmentation: % share, by value, 2016

Figure 37: France generics market value forecast: $ million, 2016-21

Figure 38: France generics market volume forecast: % of total pharma volume, 2016-21

Figure 39: Forces driving competition in the generics market in France, 2016

Figure 40: Drivers of buyer power in the generics market in France, 2016

Figure 41: Drivers of supplier power in the generics market in France, 2016

Figure 42: Factors influencing the likelihood of new entrants in the generics market in France, 2016

Figure 43: Factors influencing the threat of substitutes in the generics market in France, 2016

Figure 44: Drivers of degree of rivalry in the generics market in France, 2016

Figure 45: Germany generics market value: $ million, 2012-16

Figure 46: Germany generics market volume: % of total pharma volume, 2012-16

Figure 47: Germany generics market geography segmentation: % share, by value, 2016

Figure 48: Germany generics market value forecast: $ million, 2016-21

Figure 49: Germany generics market volume forecast: % of total pharma volume, 2016-21

Figure 50: Forces driving competition in the generics market in Germany, 2016

Figure 51: Drivers of buyer power in the generics market in Germany, 2016

Figure 52: Drivers of supplier power in the generics market in Germany, 2016

Figure 53: Factors influencing the likelihood of new entrants in the generics market in Germany, 2016

Figure 54: Factors influencing the threat of substitutes in the generics market in Germany, 2016

Figure 55: Drivers of degree of rivalry in the generics market in Germany, 2016

Figure 56: Italy generics market value: $ million, 2012-16

Figure 57: Italy generics market volume: % of total pharma volume, 2012-16

Figure 58: Italy generics market geography segmentation: % share, by value, 2016

Figure 59: Italy generics market value forecast: $ million, 2016-21

Figure 60: Italy generics market volume forecast: % of total pharma volume, 2016-21

Figure 61: Forces driving competition in the generics market in Italy, 2016

Figure 62: Drivers of buyer power in the generics market in Italy, 2016

Figure 63: Drivers of supplier power in the generics market in Italy, 2016

Figure 64: Factors influencing the likelihood of new entrants in the generics market in Italy, 2016

Figure 65: Factors influencing the threat of substitutes in the generics market in Italy, 2016

Figure 66: Drivers of degree of rivalry in the generics market in Italy, 2016

Figure 67: Japan generics market value: $ billion, 2012-16

Figure 68: Japan generics market volume: % of total pharma volume, 2012-16

Figure 69: Japan generics market geography segmentation: % share, by value, 2016

Figure 70: Japan generics market value forecast: $ billion, 2016-21

Figure 71: Japan generics market volume forecast: % of total pharma volume, 2016-21

Figure 72: Forces driving competition in the generics market in Japan, 2016

Figure 73: Drivers of buyer power in the generics market in Japan, 2016

Figure 74: Drivers of supplier power in the generics market in Japan, 2016

Figure 75: Factors influencing the likelihood of new entrants in the generics market in Japan, 2016

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports